Merieux, 1994 - Google Patents
Potent ReportMerieux, 1994
- Document ID
- 9743374649577994636
- Author
- Merieux R
- Publication year
- Publication venue
- World
External Links
- 230000003389 potentiating 0 title description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111217917A (en) | Novel coronavirus SARS-CoV-2 vaccine and preparation method thereof | |
| EP0374869A1 (en) | Recombinant DNA molecules and their method of production | |
| EA006232B1 (en) | Streptococcus antigens | |
| Leclerc et al. | The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics. | |
| JPH03285681A (en) | Vaccine | |
| CN110156896A (en) | Recombined foot-and-mouth disease virus sample particle and its preparation method and application | |
| US12064472B2 (en) | Southern cattle tick vaccine product | |
| CN104894045B (en) | A kind of recombinant Lactobacillus and its preparation method and application of coexpression VP 1 Gene of Foot-and-Mouth Disease virus and immunologic adjuvant ox IL-6 genes | |
| CA2707919C (en) | A subunit vaccine for aquaculture | |
| US9358283B2 (en) | Diatom-based vaccines | |
| CN113234654A (en) | Recombinant bacillus subtilis and application thereof | |
| CN104428417B (en) | Vaccination with recombinant yeast producing a protective humoral immune response against defined antigens | |
| CN104988107A (en) | Recombinant lactic acid bacillus efficiently expressing foot and mouth disease virus antigen genes and preparation method and application thereof | |
| JPH05501401A (en) | Vaccine or toxoid preparations and immunization methods by metastatic growth with recombinant microorganisms | |
| US6673601B1 (en) | Chimeric lyssavirus nucleic acids and polypeptides | |
| CN108822192A (en) | A kind of Actinobacillus pleuropneumoniae immune protective antigen albumin A PJL_1976 and its application | |
| Merieux | Potent Report | |
| CN108794584A (en) | A kind of Actinobacillus pleuropneumoniae immune protective antigen albumin A PJL_1380 and its application | |
| CN107446872A (en) | A kind of recombinant lactic acid bacteria vaccine strain of constitutive expression rabbit hemorrhagic disease virus VP60 albumen and its production and use | |
| CN111454989A (en) | Chimeric gene type I encephalitis B virus-like particle vaccine and preparation method and application thereof | |
| CN114437235B (en) | Recombinant fusion protein of streptococcus equi subspecies 8 proteins, and preparation method and application thereof | |
| CN111569056A (en) | Porcine rotavirus vaccine, antigen for preparing vaccine and coding sequence thereof | |
| CN113384691B (en) | Classical swine fever virus E2 protein recombinant subunit vaccine taking salmonella flagellin as molecular adjuvant and preparation method thereof | |
| NZ520600A (en) | Novel therapeutic compositions for treating infection by Lawsonia spp | |
| CN110408582B (en) | Construction and preparation of Vibrio cholerae ghosts displaying the main antigenic region of swine fever virus E2 protein |